| 2025-08-02 |
SDBJ5200156365 |
HIKMA PHARMACEUTICALS USA INC |
2733.0 kg |
300680
|
PHARMACEUTICALS |
| 2025-06-08 |
QEMLCPH00110639 |
HIKMA PHARMACEUTICALS USA INC |
6687.0 kg |
300680
|
PHARMACEUTICALS |
| 2025-05-24 |
DSVFDSV0922455 |
SAMSON MEDICAL TECHNOLOGIES L L C |
708.0 kg |
730451
|
VANCOMYCIN HCL EP ST |
| 2025-04-20 |
DSVFDSV0891026 |
SAMSON MEDICAL TECHNOLOGIES L L C |
1860.0 kg |
|
VANCOMYCIN SMARTPACK |
| 2025-04-12 |
QEMLCPH00107009 |
HIKMA PHARMACEUTICALS USA INC |
14007.0 kg |
300420
|
PHARMACEUTICALS HS CODE300420 PHARMACEUTICALS HS CODE300420 |
| 2025-03-16 |
SWOECPH00105536 |
HIKMA PHARMACEUTICALS USA INC |
7897.0 kg |
300680
|
PHARMACEUTICALS |
| 2025-01-15 |
DSVFDSV0769738 |
SAMSON MEDICAL TECHNOLOGIES L L C |
2362.0 kg |
|
VANCOMYCIN SMARTPACK VANCOMYCIN SMARTPACK |
| 2025-01-12 |
SWOECPH00101913 |
HIKMA PHARMACEUTICALS USA INC |
3661.0 kg |
300420
|
PHARMACEUTICALS HS CODE30042000 |
| 2024-12-10 |
SWOECPH00099645 |
HIKMA PHARMACEUTICALS USA INC |
15321.0 kg |
300420
|
HS CODE 30042000 PHARMACEUTICALS EXW DK-2300 COPENHAGEN S HS CODE 30042000 PHARMACEUTICALS EXW DK-2300 COPENHAGEN S |
| 2024-11-28 |
DSVFDSV0736335 |
SAMSON MEDICAL TECHNOLOGIES L L C |
1277.0 kg |
291823
|
VANCOMYCIN CIVICA 10X1G US |
| 2024-11-23 |
DSVFDSV0752577 |
CIVICA INC |
5649.0 kg |
|
VANCOMYCIN CIVICA VANCOMYCIN CIVICA VANCOMYCIN CIVICA |
| 2024-10-16 |
DSVFDSV0699663 |
SAMSON MEDICAL TECHNOLOGIES L L C |
988.0 kg |
|
VANCOMYCIN SMARTPACK |
| 2024-10-10 |
DSVFCHI0008529 |
XELLIA PHARMACEUTICALS USA LLC |
12810.0 kg |
300420
|
VANCOMYCIN INJECTION, USP 1.25G/250MLXELLIA NDA N211962 HS CODE 3004.2000TEM PERATURE TO BE SET AT +20.0 CDELIVERY TO:INTEGRATED COMMERCIAL SOLUTIONS LLC6450 LASALLE DRIVELOCKBOURNE OH 43137USA |
| 2024-10-08 |
DSVFCHI0008527 |
XELLIA PHARMACEUTICALS USA LLC |
12899.0 kg |
300420
|
VANCOMYCIN INJECTION, USP 1.25G/250ML NDA N211962 HS CODE 3004.2000TEMPERATU RE TO BE SET AT +20.0 CDELIVERY TO:INTEGRATEDCOMMERCIAL SOLUTIONS LLC6450 LASALLE DRIVELO CKBOURNE OH 43137USA |
| 2024-09-14 |
DSVFDSV0691870 |
XELLIA PHARMACEUTICALS USA LLC |
2356.0 kg |
291823
|
DAPTOMYCIN CMS INJ B2I 12X150MG US |
| 2024-09-08 |
DSVFDSV0673341 |
INTEGRATED COMMERCIAL SOLUTIONS LL |
1942.0 kg |
291823
|
DAPTOMYCIN B2I 1X500 MG US |
| 2024-08-17 |
DSVFDSV0663319 |
CIVICA INC |
4464.0 kg |
700232
|
VANCOMYCIN CIVICA US PHARMACEUTICAL PRODUCTSTEMP SET POINT +20 DEGCELTO BE STORED AT TEMPERATURE BETWEEN 15-25 DEGREES C PHARMACEUTICAL PRODUCTSTEMP SET POINT +20 DEGCELTO BE STORED AT TEMPERATURE BETWEEN 15-25 DEGREES C |
| 2024-07-27 |
KWEO75024101239 |
CIVICA |
6185.0 kg |
|
VANCOMYCIN |
| 2024-07-23 |
DSVFDSV0647025 |
XELLIA PHARMACEUTICALS USA INC |
4410.0 kg |
300680
|
PHARMACEUTICALS PHARMACEUTICALS PHARMACEUTICALS |
| 2024-07-21 |
DSVFCHI0007938 |
XELLIA PHARMACEUTICALS USA LLC |
11296.0 kg |
300420
|
VANCOMYCIN RTU BAGS (5MG/ML) NDA N21 1962 HS CODE 3004.2000TEMPERATURE TO B E SET AT +20.0 CVANCOMYCIN RTU BAGS (5MG/ML) NDA N211962 HS CODE 3004.2000 TEMPERATURE TO BE SET AT +20.0 C |
| 2024-07-03 |
DSVFDSV0620145 |
XELLIA PHARMACEUTICALS USA INC |
3696.0 kg |
271019
|
DAPTOMYCIN B2I 1X500 MG USTEMP SET POINT +5 DEG CELTO BE STORED AT TEMPERATURE BETWEEN 2-8DEGREES C |
| 2024-06-12 |
HLCUGOAODAUHF9AA |
XELLIA PHARMACEUTICALS C/O |
13518.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600229 |
| 2024-06-07 |
DSVFDSV0599370 |
SAMSON MEDICAL TECHNOLOGIES L L C |
817.0 kg |
|
VANCOMYCIN SMARTPACK |
| 2024-06-01 |
DSVFDSV0608828 |
XELLIA PHARMACEUTICALS INC |
3442.0 kg |
700232
|
DAPTO + CMS PHARMACEUTICAL PRODUCTSTO BE STORED AT TEMPERATURE BETWEEN 2-8 DEGREES C |
| 2024-05-15 |
DSVFDSV0593521 |
INTEGRATED COMMERCIALIZATION SOLUTI |
4574.0 kg |
902230
|
CMS / DAPTO FDF CMS INJ B2I 12X150MG US X 4,148.000 DAPTOMYCIN PREMIER 500 MG US X 40,000.000 DAPTOMYCIN B2I 1X350 MG US X 41,125.000 CMS INJ B2I 12X150MG US X 4,148.000 DAPTOMYCIN PREMIER 500 MG US X 40,000.000 DAPTOMYCIN B2I 1X350 MG US X 41,125.000 |
| 2024-05-12 |
KWEO75024101046 |
CIVICA INC |
4177.0 kg |
|
VANCOMYCIN |
| 2024-05-04 |
KWEO75024100973 |
CIVICA |
5762.0 kg |
|
VANCOMYCIN |
| 2024-05-02 |
HLCUGOAOD36330AA |
XELLIA PHARMACEUTICALS C/O |
4707.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600167 |
| 2024-04-27 |
HLCUGOAOC71494AA |
XELLIA PHARMACEUTICALS C/O |
27192.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600168 VANCOMYCIN HS CODE 3004.2000 NDA NR 600169 |
| 2024-04-11 |
HLCUGOAOB87835AA |
XELLIA PHARMACEUTICALS C/O |
54092.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600131+600132 VANCOMYCIN HS CODE 3004.2000 NDA NR 600135 VANCOMYCIN HS CODE 3004.2000 NDA NR 600129+600130 VANCOMYCIN HS CODE 3004.2000 NDA NR 600133+600134 |
| 2024-04-09 |
HLCUGOAOB87920AA |
XELLIA PHARMACEUTICALS C/O |
51190.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600112+600113 VANCOMYCIN HS CODE 3004.2000 NDA NR 600111 VANCOMYCIN HS CODE 3004.2000 NDA NR 600114+600115 VANCOMYCIN HS CODE 3004.2000 NDA NR 600116+600117 |
| 2024-04-04 |
KWEO75024100924 |
CIVICA |
5135.0 kg |
|
DAPTOMYCIN PREMIER |
| 2024-04-03 |
KWEO75024100971 |
XELLIA PHARMACEUTICALE INC |
1755.0 kg |
382450
|
VANCOMYCIB WET BASE |
| 2024-03-20 |
HLCUGOAOB94241AA |
XELLIA PHARMACEUTICALS C/O |
56473.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 600084-600085-600086 VANCOMYCIN HS CODE 3004.2000 NDA NR 600087 VANCOMYCIN HS CODE 3004.2000 NDA NR 600088 VANCOMYCIN HS CODE 3004.2000 NDA NR 600079 VANCOMYCIN HS CODE 3004.2000 NDA NR 600080+600081 |
| 2024-03-18 |
KWEO75024100886 |
XELLIA LTD |
2150.0 kg |
|
DAPTOMYCIN & CMS INJ |
| 2024-03-12 |
KWEO75024100819 |
CIVICA |
5390.0 kg |
|
VANCOMYCIN |
| 2024-02-19 |
KWEO75024100809 |
CIVICA INC |
4476.0 kg |
|
VANCOMYCIN , DAPTOMYCIN |
| 2024-02-16 |
KWEO750240100810 |
XELLIA LTD |
4995.0 kg |
|
DAPTOMYCIN & CMS INJ |
| 2024-01-22 |
KWEO75024100647 |
SAMSON MEDICAL TECHNOLOGIES L L C |
378.0 kg |
|
VANCOMYCIN |
| 2024-01-19 |
LISTAAL000138917 |
XELLIA PHARMACEUTICALS USA LLC |
3807.0 kg |
190120
|
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP,100 GRAM SMARTPAKBATCH NO.: 3164509; 3164510; 3164512; 3164511; 3166678COLLI NOS.: 60-74TEMPERATURE BETWEEN +15 - +25 DEGR CEL VANCOMYCIN CIVICA 10X1G US + VANCOMYCIN CIVICA 5G USBATCH NO.: 31XXXXX; 31XXXXX; 31XXXXX; 31XXXXX; 31XXXXXCOLLI NOS.: XX-XXTEMPERATURE BETWEEN +15 - +25 DEGR CEL |
| 2024-01-08 |
KWEO75024100640 |
XELLIA LTD |
3746.0 kg |
|
DAPTOMYCIN B21 |
| 2024-01-02 |
HLCUGOANK69717AA |
XELLIA PHARMACEUTICALS C/O |
40742.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13190 VANCOMYCIN HS CODE 3004.2000 NDA NR 13188 VANCOMYCIN HS CODE 3004.2000 NDA NR 13189 VANCOMYCIN HS CODE 3004.2000 NDA NR 13191+13192+13193 |
| 2023-12-29 |
HLCUGOANK69622AA |
XELLIA PHARMACEUTICALS C/O |
31676.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13175 VANCOMYCIN HS CODE 3004.2000 NDA NR 13173+13174 VANCOMYCIN HS CODE 3004.2000 NDA NR 13171+13172 |
| 2023-12-28 |
KWEO75024100613 |
XELLIA LTD |
3685.0 kg |
|
DAPTOMYCIN |
| 2023-12-28 |
LISTAAL000135554 |
XELLIA PHARMACEUTICALS USA LLC |
1496.0 kg |
853922
|
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP,100 GRAM SMARTPAKBATCH NO.: 3164509; 3164510; 3164512; 3164511; 3166678COLLI NOS.: 60-74TEMPERATURE BETWEEN +15 - +25 DEGR CEL |
| 2023-12-21 |
KWEO75024100653 |
XELLIA PHARMACEUTICALS C/O ICS LLC |
3685.0 kg |
|
DAPTOMYCIN PREMIER |
| 2023-12-14 |
HLCUGOANK11735AA |
XELLIA PHARMACEUTICALS C/O |
24378.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13150+12301 VANCOMYCIN HS CODE 3004.2000 NDA NR 131512+12303 |
| 2023-12-08 |
HLCUGOANJAWRR0AA |
XELLIA PHARMACEUTICALS C/O |
39809.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13129 VANCOMYCIN HS CODE 3004.2000 NDA NR 13130 VANCOMYCIN HS CODE 3004.2000 NDA NR 13131 |
| 2023-12-06 |
KWEO75024100601 |
XELLIA LTD |
3806.0 kg |
|
DAPTOMYCIN |
| 2023-11-27 |
HLCUGOANJATAS7AA |
XELLIA PHARMACEUTICALS C/O |
30453.0 kg |
300420
|
VANCOMYCIN HS CODE 3004.2000 NDA NR 13119 VANCOMYCIN HS CODE 3004.2000 NDA NR 13117+13118 VANCOMYCIN HS CODE 3004.2000 NDA NR 13115+13116 |